Novartis AG
CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE
Last updated:
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of a tumor antigen as described herein by administration of a cell comprising a chimeric antigen receptor that binds a B-Cell antigen and a chimeric antigen receptor which binds a tumor antigen.
Status:
Application
Type:
Utility
Filling date:
3 Mar 2017
Issue date:
10 Sep 2020